Cat. No. |
Product Name |
Information |
PC-72930 |
YTK-105 linker conjugate 1
AUTOTAC conjugate
|
YTK-105 linker conjuate 1 is a PEG linker added to p62-ZZ ligand YTK-105 for AUTOTAC design. |
PC-72929 |
YOK-2204 linker conjugate 1
AUTOTAC conjugate
|
YOK-2204 linker conjuate 1 is a PEG linker added to p62-ZZ ligand YOK-2204 for AUTOTAC design. |
PC-72928 |
YOK-1304 AUTOTAC intermidate 1
AUTOTAC conjugate
|
YOK-1304 AUTOTAC intermidate 1 is an intermidate for AUTOTAC design. |
PC-72927 |
p62-ZZ ligand YTK-105
p62-ZZ ligand
|
YTK-105 is a small molecule p62-ZZ domain ligand, activate p62-dependent selective macroautophag, used for AUTOTAC design. |
PC-72926 |
p62-ZZ ligand YOK-2204
p62-ZZ ligand
|
YOK-2204 is a small molecule p62-ZZ domain ligand, activate p62-dependent selective macroautophag, used for AUTOTAC design. |
PC-72925 |
p62-ZZ ligand YOK-1304
p62-ZZ ligand
|
YOK-1304 is a small molecule p62-ZZ domain ligand, activate p62-dependent selective macroautophag, used for AUTOTAC design. |
PC-72911 |
GNE-987
BET degrader
|
GNE-987 (GNE987) is a highly potent chimeric BET degrader, exhibits BRD4 degradation activity in EOL-1 AML cell line with DC50 of 30 pM. |
PC-72840 |
MS9715
NSD3 PROTAC
|
MS9715 (MS 9715) is a NSD3-targeting PROTAC designed by linking BI-9321, a NSD3 antagonist, which binds NSD3's PWWP1 domain, with an E3 ligase VHL ligand. |
PC-72837 |
NJH-2-057
CFTR DUBTAC
|
NJH-2-057 is a novel CFTR DUBTAC via linking the OTUB1 recruiter EN523 to the CFTR chaperone lumacaftor with C5 alkyl linkers. |
PC-72798 |
AU-15330
SWI/SNF ATPase PROTAC
|
AU-15330 (AU15330) is a highly specific and VHL-dependent PROTAC degrader of SWI/SNF ATPase components (SMARCA2, SMARCA4 and PBRM1), shows preferential cytotoxicity in enhancer-binding transcription factor-addicted cancers at low nanomolar concentrations. |
PC-72782 |
GSK215
FAK PROTAC
|
GSK215 is a potent, selective, FAK-degrading Proteolysis Targeting Chimera (PROTAC) based on a binder for the VHL E3 ligase and the known FAK inhibitor VS-4718. |
PC-72644 |
CFT-2718
BRD4 PROTAC
|
CFT-2718 (CFT2718) is a benzotriazoloazepine-based BRD4 degrader, rapidly and selectively degrade BRD4 in vitro in a CRBN-dependent manner (DC90=10 nM, 293T cells). |